These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22200437)

  • 61. [Research progress on the protective effect of Ghrelin on acute and chronic liver injury].
    Yang Y; Qin Y
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):625-628. PubMed ID: 32791801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical application of ghrelin for chronic respiratory diseases.
    Matsumoto N; Nakazato M
    Methods Enzymol; 2012; 514():399-407. PubMed ID: 22975067
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Ghrelin and inflammation].
    Liang WY; Li ZR; Li Y
    Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):129-32. PubMed ID: 23847925
    [No Abstract]   [Full Text] [Related]  

  • 64. Nutrition: Can ghrelin improve appetite in uremic wasting?
    Carrero JJ; Stenvinkel P
    Nat Rev Nephrol; 2009 Dec; 5(12):672-3. PubMed ID: 19935812
    [No Abstract]   [Full Text] [Related]  

  • 65. Letter: Essentiality of histidine in uremia.
    McLaren DS
    N Engl J Med; 1973 Dec; 289(25):1372-3. PubMed ID: 4753036
    [No Abstract]   [Full Text] [Related]  

  • 66. Muscle metabolism in uremia and the effect of amino acid supplementation.
    Van der Niepen P; Allein S; Verbeelen D
    Nephron; 1998 Aug; 79(4):387-98. PubMed ID: 9689153
    [No Abstract]   [Full Text] [Related]  

  • 67. [Ghrelin and its role in health and disease].
    Tereshchenko IV; Kaiushev PE
    Ter Arkh; 2013; 85(4):98-101. PubMed ID: 23808302
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of changes in lipid metabolism disorder, insulin resistance, inflammation and intestinal flora in patients in different stages of uremia.
    Zhang X; Li Z; Xie J; Huang H; Xiang Y; Li C
    Minerva Med; 2023 Apr; 114(2):284-286. PubMed ID: 33832212
    [No Abstract]   [Full Text] [Related]  

  • 69. Anabolic interventions in ESRD: light at the end of the tunnel?
    Hakim RM; Ikizler TA
    Am J Kidney Dis; 2009 Aug; 54(2):201-4. PubMed ID: 19556045
    [No Abstract]   [Full Text] [Related]  

  • 70. Markers of oxidative stress in uremia.
    Lipinski B
    Kidney Int; 2004 Jan; 65(1):339-40; author reply 340. PubMed ID: 14675074
    [No Abstract]   [Full Text] [Related]  

  • 71. Cardioprotective effects of ghrelin in heart failure: from gut to heart.
    Khatib MN; Simkhada P; Gode D
    Heart Views; 2014 Jul; 15(3):74-6. PubMed ID: 25538820
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adipose tissue metabolic changes in chronic kidney disease.
    Serrano E; Shenoy P; Martinez Cantarin MP
    Immunometabolism (Cobham); 2023 Apr; 5(2):e00023. PubMed ID: 37128293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Higher unacylated ghrelin and insulin sensitivity following dietary restriction and weight loss in obese humans.
    Barazzoni R; Gortan Cappellari G; Zanetti M; Klaus KA; Semolic A; Johnson ML; Nair KS
    Clin Nutr; 2021 Feb; 40(2):638-644. PubMed ID: 32641220
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ghrelin forms in the modulation of energy balance and metabolism.
    Gortan Cappellari G; Barazzoni R
    Eat Weight Disord; 2019 Dec; 24(6):997-1013. PubMed ID: 30353455
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Malnutrition in Chronic Kidney Disease.
    Iorember FM
    Front Pediatr; 2018; 6():161. PubMed ID: 29974043
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin Resistance Is Associated with Interleukin 1β (IL-1β) in Non-Diabetic Hemodialysis Patients.
    Bi X; Ai H; Wu Q; Fan Q; Ding F; Hu C; Ding W
    Med Sci Monit; 2018 Feb; 24():897-902. PubMed ID: 29436520
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of muscle wasting in chronic kidney disease.
    Wang XH; Mitch WE
    Nat Rev Nephrol; 2014 Sep; 10(9):504-16. PubMed ID: 24981816
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
    Wang CJ; Bao XR; Du GW; Wang Y; Chen K; Shen ML; Wang LZ
    Int Urol Nephrol; 2014 Aug; 46(8):1609-17. PubMed ID: 24839054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ghrelin and leptin pathophysiology in chronic kidney disease.
    Gunta SS; Mak RH
    Pediatr Nephrol; 2013 Apr; 28(4):611-6. PubMed ID: 23229444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin resistance in patients with chronic kidney disease.
    Liao MT; Sung CC; Hung KC; Wu CC; Lo L; Lu KC
    J Biomed Biotechnol; 2012; 2012():691369. PubMed ID: 22919275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.